Feasibility and Validation of the Japanese Version of the EQ-HWB

Author(s)

Noto S1, Shiroiwa T2, Murata T3, Saito S4
1Niigata University of Health and Welfare, Niigata, Japan, 2National Institute of Public Health, Wako, Saitama, Japan, 3CRECON Medical Assessment Inc., Tokyo, Shibuya, Japan, 4Okayama University, Okayama, 33, Japan

Presentation Documents

OBJECTIVES: The EQ-HWB is being developed as a separate instrument to assess various impacts on the health and wellbeing of care recipients and caregivers. It is currently being translated into multiple languages, each validated for validity and reliability. This study aimed to verify the reliability and validity of the Japanese version of the EQ-HWB.

METHODS: We simultaneously measured the EQ-5D-5L and EQ-HWB in patients with cerebrovascular disease, Parkinson's disease, cardiac disease, cancer, orthopedic disease, and collagen disease in three hospitals in Japan. Demographic characteristics and ADL data were also included in the study. After examining the data distribution, reliability was tested using the retest method, and validity was examined in terms of correlations and response patterns in each domain.

RESULTS: A total of 274 patients were enrolled in this study. Of these, 42 had stroke, 61 had orthopedic disease, 54 had cardiac disease, 52 had Parkinson's disease, and 45 had connective tissue diseases. Overall, the ceiling effect was identified for vision, hearing, loneliness, and support. On the other hand, the floor effect was identified in meaningful activities [19%], belonging [28%], stigma [20%], satisfaction [13%], and body pain [13%]. Moderate to strong correlations were found between conceptually overlapping dimensions of the EQ-5D-5L and EQ-HWB (e.g., mobility [r=0.612], self-care [r=0.592]). Conversely, no correlations were found between conceptually distinct dimensions (e.g., vision, sleep, belonging, stigma, satisfaction).

CONCLUSIONS:

The results of this study showed that the EQ-HWB has high reliability and validity even in patients with various diseases, especially in the areas not included in the EQ-5D-5L, i.e., lonely, thinking clearly, and concentrating items, as previously reported by Monteiro et al. (2022), with discriminant validity. Views expressed by the authors in the publication do not necessarily reflect the views of EuroQol.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

PCR164

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×